While individual compound contributions are impossible to isolate in a polypharmacy approach, the log reports impressive body composition changes with maintained training performance
For clinics that use or emphasize compounded drugs, availability can vary by state and pharmacy, and compounded GLP-1s are not FDA approved
Retatrutides unique mechanismactivating glucagon, GLP-1 and GIP receptorsreduces appetite, increases energy expenditure and improves insulin sensitivity
Individual results outside such a setting will vary based on starting point, dose, adherence, diet, activity, and many other factors
While large-scale randomized controlled trials (RCTs) have focused on higher-dose protocols for regulatory approval, a growing number of physicians are reporting excellent results at significantly lower doses , especially in individuals who are metabolically healthy or seeking lifestyle optimization rather than aggressive weight loss
Forgetting dose floors: The calculator always floors the number of doses per vial to avoid overestimating